cisplatin - CISMeF

Preferred Label : cisplatin;

MeSH definition : An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.;

MeSH synonym : cis-diamminedichloroplatinum(ii); cis-platinum; platinum diamminodichloride; diamminodichloride, platinum; cis-diamminedichloroplatinum; cis diamminedichloroplatinum; cis-dichlorodiammineplatinum(ii); cis platinum; dichlorodiammineplatinum;

MeSH hyponym : platino; platinol; NSC-119875; biocisplatinum; platidiam;

MeSH CAS label : platinum, diamminedichloro-, (SP-4-2)-;

MeSH Related Number : 15663-27-1 (Cisplatin);

Registry Number MeSH : 15663-27-1;

Wikipedia link : https://en.wikipedia.org/wiki/Cisplatin;

Codes EINECS : 239-733-8;

Is substance : O;

medicament (CISMeF) : O;

UNII : Q20Q21Q62J;

InChIKey : LXZZYRPGZAFOLE-UHFFFAOYSA-L;

Details

Origin ID

D002945;

UMLS CUI

C0008838;

ATC code(s)
- cisplatin [ATC Code]
ATC code(s)
- cisplatin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Cisplatin poisoning (disorder) [SNOMED CT concept]
- cisplatin [Substance BNPC]
Currated CISMeF NLP mapping
- CISplatin [LOINC component]
- Cisplatin [ICD-11 Extension code]
- Cisplatin [ICHI extension code]
- Cisplatin [NCIt concept]
- Cisplatin (substance) [SNOMED CT concept]
- cisplatin [SNOMED Notion]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- cross-linking reagents [MeSH Descriptor]
- radiation-sensitizing agents [MeSH Descriptor]
Record concept(s)
- NSC-119875 [MeSH concept]
- biocisplatinum [MeSH concept]
- cisplatin [MeSH concept]
- platidiam [MeSH concept]
- platino [MeSH concept]
- platinol [MeSH concept]
Related MeSH Supplementary Concept(s)
- (PtCl2(4,7-H-5-methyl-7-oxo(1,2,4)triazolo(1,5-a)pyrimidine)2) [MeSH Supplementary Concept]
- 5-FU-CDDP protocol [MeSH Supplementary Concept]
- ACV protocol [MeSH Supplementary Concept]
- ADOC protocol [MeSH Supplementary Concept]
- AP protocol 1 [MeSH Supplementary Concept]
- APEL protocol [MeSH Supplementary Concept]
- APO protocol 2 [MeSH Supplementary Concept]
- ASHAP protocol [MeSH Supplementary Concept]
- B 85-0040 [MeSH Supplementary Concept]
- BAP protocol 2 [MeSH Supplementary Concept]
- BAP regimen [MeSH Supplementary Concept]
- BAPP protocol [MeSH Supplementary Concept]
- BBVDD protocol [MeSH Supplementary Concept]
- BCMV protocol [MeSH Supplementary Concept]
- BEMP protocol 2 [MeSH Supplementary Concept]
- BEP protocol [MeSH Supplementary Concept]
- BEPV protocol [MeSH Supplementary Concept]
- BIP protocol [MeSH Supplementary Concept]
- BOMP protocol [MeSH Supplementary Concept]
- BOP-CISCA-POMB-ACE regimen [MeSH Supplementary Concept]
- BOPP protocol [MeSH Supplementary Concept]
- BV-CAP protocol [MeSH Supplementary Concept]
- CAB protocol [MeSH Supplementary Concept]
- CAE-P protocol [MeSH Supplementary Concept]
- CAF-PH protocol [MeSH Supplementary Concept]
- CAP protocol 1 [MeSH Supplementary Concept]
- CAP therapy protocol [MeSH Supplementary Concept]
- CAP-1 protocol [MeSH Supplementary Concept]
- CAP-M protocol [MeSH Supplementary Concept]
- CAPABLE protocol [MeSH Supplementary Concept]
- CAPF protocol [MeSH Supplementary Concept]
- CBC protocol [MeSH Supplementary Concept]
- CCC protocol [MeSH Supplementary Concept]
- CCE protocol [MeSH Supplementary Concept]
- CCP protocol [MeSH Supplementary Concept]
- CE-AVN protocol [MeSH Supplementary Concept]
- CE-CAP protocol [MeSH Supplementary Concept]
- CEBA combination [MeSH Supplementary Concept]
- CECA protocol [MeSH Supplementary Concept]
- CEP combination [MeSH Supplementary Concept]
- CEVP protocol [MeSH Supplementary Concept]
- CF regimen [MeSH Supplementary Concept]
- CFB protocol [MeSH Supplementary Concept]
- CGV protocol [MeSH Supplementary Concept]
- CHAMP-5 protocol [MeSH Supplementary Concept]
- CIF protocol [MeSH Supplementary Concept]
- CIP protocol [MeSH Supplementary Concept]
- CISCA protocol [MeSH Supplementary Concept]
- CISCA(II)-VB(IV) protocol [MeSH Supplementary Concept]
- CMF protocol [MeSH Supplementary Concept]
- CNR-NEO 2 protocol [MeSH Supplementary Concept]
- COB protocol [MeSH Supplementary Concept]
- COBDP regimen [MeSH Supplementary Concept]
- COMPA regimen [MeSH Supplementary Concept]
- COMPE protocol [MeSH Supplementary Concept]
- COPAC protocol [MeSH Supplementary Concept]
- COPE regimen [MeSH Supplementary Concept]
- COPU protocol [MeSH Supplementary Concept]
- COSS-86 protocol [MeSH Supplementary Concept]
- CP protocol [MeSH Supplementary Concept]
- CPDD protocol [MeSH Supplementary Concept]
- CPT protocol [MeSH Supplementary Concept]
- CPVP protocol [MeSH Supplementary Concept]
- CVACE protocol [MeSH Supplementary Concept]
- CVB protocol [MeSH Supplementary Concept]
- Cis-VACD protocol [MeSH Supplementary Concept]
- CisEBP protocol [MeSH Supplementary Concept]
- D 17872 [MeSH Supplementary Concept]
- DBCT protocol [MeSH Supplementary Concept]
- DBPT protocol [MeSH Supplementary Concept]
- DBPT regimen [MeSH Supplementary Concept]
- DCEP protocol [MeSH Supplementary Concept]
- DCM-Dex-CDDP [MeSH Supplementary Concept]
- DDP-BLM protocol [MeSH Supplementary Concept]
- DEB-M protocol [MeSH Supplementary Concept]
- DECAV protocol [MeSH Supplementary Concept]
- DHAP protocol [MeSH Supplementary Concept]
- DICE protocol [MeSH Supplementary Concept]
- DOP protocol [MeSH Supplementary Concept]
- DT PACE regimen [MeSH Supplementary Concept]
- DT-PACE protocol [MeSH Supplementary Concept]
- DVP (cisplatin) [MeSH Supplementary Concept]
- DVP protocol [MeSH Supplementary Concept]
- EAP protocol [MeSH Supplementary Concept]
- ECBC protocol [MeSH Supplementary Concept]
- ECP regimen [MeSH Supplementary Concept]
- ECT chemotherapy protocol [MeSH Supplementary Concept]
- EDAP regimen [MeSH Supplementary Concept]
- EDP protocol [MeSH Supplementary Concept]
- EEP protocol [MeSH Supplementary Concept]
- EEPFL protocol [MeSH Supplementary Concept]
- EFP protocol [MeSH Supplementary Concept]
- ELETOP protocol [MeSH Supplementary Concept]
- ENSG 3C protocol [MeSH Supplementary Concept]
- EP-OMB protocol [MeSH Supplementary Concept]
- EPO protocol [MeSH Supplementary Concept]
- ESAP protocol [MeSH Supplementary Concept]
- ESHAP regimen [MeSH Supplementary Concept]
- ESHAP regimen, modified [MeSH Supplementary Concept]
- EVAC-G-CSF protocol [MeSH Supplementary Concept]
- EVAP regimen [MeSH Supplementary Concept]
- EpPt-OMB protocol [MeSH Supplementary Concept]
- FACP protocol [MeSH Supplementary Concept]
- FADIP protocol [MeSH Supplementary Concept]
- FAMP protocol [MeSH Supplementary Concept]
- FAP protocol [MeSH Supplementary Concept]
- FAP regimen [MeSH Supplementary Concept]
- FAP2 protocol [MeSH Supplementary Concept]
- FAPEL protocol [MeSH Supplementary Concept]
- FCT protocol [MeSH Supplementary Concept]
- FEMTX-P protocol [MeSH Supplementary Concept]
- FEP protocol [MeSH Supplementary Concept]
- FEPA protocol [MeSH Supplementary Concept]
- FLAP protocol [MeSH Supplementary Concept]
- FLAP regimen [MeSH Supplementary Concept]
- FLEP protocol [MeSH Supplementary Concept]
- FLEP regimen [MeSH Supplementary Concept]
- FLMP protocol [MeSH Supplementary Concept]
- FLUDAP protocol [MeSH Supplementary Concept]
- FMP protocol [MeSH Supplementary Concept]
- FP protocol [MeSH Supplementary Concept]
- FPEPIR regimen [MeSH Supplementary Concept]
- FTP protocol [MeSH Supplementary Concept]
- FVP protocol [MeSH Supplementary Concept]
- GAP protocol [MeSH Supplementary Concept]
- GDP protocol [MeSH Supplementary Concept]
- GIP protocol [MeSH Supplementary Concept]
- HAC protocol [MeSH Supplementary Concept]
- HD-CEP regimen [MeSH Supplementary Concept]
- HFAP protocol [MeSH Supplementary Concept]
- HLFP regimen [MeSH Supplementary Concept]
- HOP protocol [MeSH Supplementary Concept]
- IAP protocol [MeSH Supplementary Concept]
- ICE protocol 1 [MeSH Supplementary Concept]
- IMAP protocol [MeSH Supplementary Concept]
- K1 protocol [MeSH Supplementary Concept]
- M-FLP protocol [MeSH Supplementary Concept]
- M-VAC protocol [MeSH Supplementary Concept]
- M-VEC protocol [MeSH Supplementary Concept]
- MAC-VD protocol [MeSH Supplementary Concept]
- MADDOC protocol [MeSH Supplementary Concept]
- MAP protocol [MeSH Supplementary Concept]
- MBCF protocol [MeSH Supplementary Concept]
- MBD protocol [MeSH Supplementary Concept]
- MC protocol [MeSH Supplementary Concept]
- MCF protocol [MeSH Supplementary Concept]
- MEC protocol 1 [MeSH Supplementary Concept]
- MEC protocol 2 [MeSH Supplementary Concept]
- MECCA protocol [MeSH Supplementary Concept]
- MEP regimen [MeSH Supplementary Concept]
- MEPH protocol [MeSH Supplementary Concept]
- MEPP protocol [MeSH Supplementary Concept]
- MICE regimen [MeSH Supplementary Concept]
- MIFAP regimen [MeSH Supplementary Concept]
- MINE-ESHAP protocol [MeSH Supplementary Concept]
- MIP protocol [MeSH Supplementary Concept]
- MP regimen [MeSH Supplementary Concept]
- MPEMi protocol [MeSH Supplementary Concept]
- MPEpiE protocol [MeSH Supplementary Concept]
- MPEpiV protocol [MeSH Supplementary Concept]
- MVP protocol 2 [MeSH Supplementary Concept]
- MVP-CAB protocol [MeSH Supplementary Concept]
- MiPE protocol [MeSH Supplementary Concept]
- NIACF regimen [MeSH Supplementary Concept]
- NIP regimen [MeSH Supplementary Concept]
- NOV 002 [MeSH Supplementary Concept]
- NaPIM protocol [MeSH Supplementary Concept]
- OC-HDP protocol [MeSH Supplementary Concept]
- OPEC OJEC protocol [MeSH Supplementary Concept]
- OPEC protocol 1 [MeSH Supplementary Concept]
- OPEC-D protocol [MeSH Supplementary Concept]
- OS 87 protocol [MeSH Supplementary Concept]
- PAB-CAP protocol [MeSH Supplementary Concept]
- PADIC protocol [MeSH Supplementary Concept]
- PAE protocol [MeSH Supplementary Concept]
- PAMP protocol [MeSH Supplementary Concept]
- PAV-M protocol [MeSH Supplementary Concept]
- PAVE protocol 2 [MeSH Supplementary Concept]
- PAVI protocol [MeSH Supplementary Concept]
- PBMF protocol [MeSH Supplementary Concept]
- PBML protocol [MeSH Supplementary Concept]
- PCMF protocol [MeSH Supplementary Concept]
- PCV regimen [MeSH Supplementary Concept]
- PDN-1 [MeSH Supplementary Concept]
- PE regimen [MeSH Supplementary Concept]
- PEA regimen [MeSH Supplementary Concept]
- PEA-M regimen [MeSH Supplementary Concept]
- PELF protocol 2 [MeSH Supplementary Concept]
- PEM protocol [MeSH Supplementary Concept]
- PEP protocol [MeSH Supplementary Concept]
- PET protocol [MeSH Supplementary Concept]
- PET regimen [MeSH Supplementary Concept]
- PEV-B protocol [MeSH Supplementary Concept]
- PFAP protocol [MeSH Supplementary Concept]
- PFL protocol [MeSH Supplementary Concept]
- PFL-MP protocol [MeSH Supplementary Concept]
- PFLI-alpha protocol [MeSH Supplementary Concept]
- PIAF regimen [MeSH Supplementary Concept]
- PIN protocol [MeSH Supplementary Concept]
- PMFV protocol [MeSH Supplementary Concept]
- PMU protocol [MeSH Supplementary Concept]
- PMUE protocol [MeSH Supplementary Concept]
- PMUE protocol 2 [MeSH Supplementary Concept]
- POMACE protocol [MeSH Supplementary Concept]
- POMB-ACE regimen [MeSH Supplementary Concept]
- POMB-ACE-PAV regimen [MeSH Supplementary Concept]
- POMP regimen [MeSH Supplementary Concept]
- PP regimen [MeSH Supplementary Concept]
- PPA protocol [MeSH Supplementary Concept]
- PPM protocol [MeSH Supplementary Concept]
- PTP protocol [MeSH Supplementary Concept]
- PVA protocol [MeSH Supplementary Concept]
- PVB protocol [MeSH Supplementary Concept]
- PVC protocol [MeSH Supplementary Concept]
- PVP protocol 3 [MeSH Supplementary Concept]
- PVP protocol 4 [MeSH Supplementary Concept]
- PVeBV protocol [MeSH Supplementary Concept]
- S-1 plus cisplatin [MeSH Supplementary Concept]
- SPI-077 B103 [MeSH Supplementary Concept]
- SPI-77, liposomal [MeSH Supplementary Concept]
- SSG IX protocol [MeSH Supplementary Concept]
- STAMP-I protocol [MeSH Supplementary Concept]
- T10 A protocol [MeSH Supplementary Concept]
- TAP protocol [MeSH Supplementary Concept]
- TCAP protocol [MeSH Supplementary Concept]
- TCF protocol [MeSH Supplementary Concept]
- TEMP protocol [MeSH Supplementary Concept]
- THP-FLPM protocol [MeSH Supplementary Concept]
- TIP regimen [MeSH Supplementary Concept]
- TP protocol [MeSH Supplementary Concept]
- TPF protocol [MeSH Supplementary Concept]
- TPFL4 regimen [MeSH Supplementary Concept]
- TPFL5 protocol [MeSH Supplementary Concept]
- VAB II protocol [MeSH Supplementary Concept]
- VAB-6 regimen [MeSH Supplementary Concept]
- VAB-III protocol [MeSH Supplementary Concept]
- VAB-IV protocol [MeSH Supplementary Concept]
- VCH protocol [MeSH Supplementary Concept]
- VCPC protocol [MeSH Supplementary Concept]
- VDA-P protocol [MeSH Supplementary Concept]
- VDD protocol [MeSH Supplementary Concept]
- VEP combination [MeSH Supplementary Concept]
- VIP protocol 2 [MeSH Supplementary Concept]
- VIP protocol 3 [MeSH Supplementary Concept]
- VIP-B protocol [MeSH Supplementary Concept]
- VIP-E protocol [MeSH Supplementary Concept]
- VIP-VB protocol [MeSH Supplementary Concept]
- VMBP protocol [MeSH Supplementary Concept]
- VMP protocol [MeSH Supplementary Concept]
- VMP-CIsCF protocol [MeSH Supplementary Concept]
- VP-P protocol [MeSH Supplementary Concept]
- VPC regimen [MeSH Supplementary Concept]
- VPCBAE protocol [MeSH Supplementary Concept]
- VPCP protocol [MeSH Supplementary Concept]
- VeIP protocol [MeSH Supplementary Concept]
- ViFuP protocol [MeSH Supplementary Concept]
- VlhP protocol [MeSH Supplementary Concept]
- aquahydroxydiamminoplatinum [MeSH Supplementary Concept]
- arsenoplatin-1 [MeSH Supplementary Concept]
- bis(6-aminoquinoline)dichloroplatinum(II) [MeSH Supplementary Concept]
- chlorodiethylenetriamine platinum [MeSH Supplementary Concept]
- chlorodiethylenetriamine platinum(II)-S-methyl-glutathione complex [MeSH Supplementary Concept]
- chlorodiethylenetriamine platinum(II)-glutathione complex [MeSH Supplementary Concept]
- cis-diammineplatinum(II)-polyglutamic acid complex [MeSH Supplementary Concept]
- cis-platinum dichloride bis(diethyl 4-pyridylmethylphosphonate) [MeSH Supplementary Concept]
- cisplatin, methionine drug combination [MeSH Supplementary Concept]
- cisplatin-4-methylpyridine [MeSH Supplementary Concept]
- cisplatin-DNA adduct [MeSH Supplementary Concept]
- cisplatin-deoxy(adenosine monophosphate guanosine) adduct [MeSH Supplementary Concept]
- cisplatin-deoxy(guanosine monophosphate guanosine) adduct [MeSH Supplementary Concept]
- cisplatin-guanosine adduct [MeSH Supplementary Concept]
- cisplatin-procaine complex [MeSH Supplementary Concept]
- deoxyadenylyl-thymidyl-deoxyguanylyl-deoxyguanosine-cisplatin complex [MeSH Supplementary Concept]
- diaminneplatinum(II)-chlorocholylglycinate [MeSH Supplementary Concept]
- diammine-diiodoplatin [MeSH Supplementary Concept]
- diamminediaqua platinum(II) [MeSH Supplementary Concept]
- diamminedichlorodihydroxyplatinum IV [MeSH Supplementary Concept]
- diamminemonoaquamonochloroplatinum(II) [MeSH Supplementary Concept]
- diamminetetrachloroplatinum(II) [MeSH Supplementary Concept]
- dichlorbis(benzothiazole)platinum(II) [MeSH Supplementary Concept]
- dichloro(4,5-dimethyl-2-phenylenediamine-N,N')platinum(II) [MeSH Supplementary Concept]
- dichlorobis(glycylglycine ethyl ester)platinum II [MeSH Supplementary Concept]
- dichlorobis(tranylcypromine)platinum(II) [MeSH Supplementary Concept]
- disodium hexachloroplatinate [MeSH Supplementary Concept]
- lipoplatin [MeSH Supplementary Concept]
- m-BOP protocol [MeSH Supplementary Concept]
- mito-MBD protocol [MeSH Supplementary Concept]
- modified M-VAC protocol [MeSH Supplementary Concept]
- opTPFL regimen [MeSH Supplementary Concept]
- plachitin [MeSH Supplementary Concept]
- poly(ethylene glycol)-poly(cisplatin-aspartic acid) [MeSH Supplementary Concept]
- rizzoli IOR protocol [MeSH Supplementary Concept]
- selenium-cisplatin conjugate [MeSH Supplementary Concept]
- silaplatin [MeSH Supplementary Concept]
- transplatin [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Platinum [DeCS]
- Product containing cisplatin (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Inorganic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- CISplatin [LOINC component]
- Cisplatin [ICD-11 Extension code]
- Cisplatin [NCIt concept]
- Cisplatin (substance) [SNOMED CT concept]
- Product containing cisplatin (medicinal product) [SNOMED CT concept]
- cisplatin [ATC Code]
- cisplatin [Substance BNPC]
- cisplatin [SNOMED Notion]
Validated automatic mappings to BTNT
- cisplatin [ATC Code]
Validated automatic mappings to NTBT
- Platinum [LOINC component]
- Platinum [NCIt concept]
- Platinum (substance) [SNOMED CT concept]
- platinum [Substance BNPC]
- platinum [Radlex concept]
- platinum, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients